New p57 KIP2 mutations in Beckwith-Wiedemann syndrome
I. Hatada(National Cerebral and Cardiovascular Center), Tsunehiro Mukai(National Cerebral and Cardiovascular Center), Akira Nabetani(National Cerebral and Cardiovascular Center), Zhenghan Xin(National Cerebral and Cardiovascular Center), Hiroko Morisaki(National Cerebral and Cardiovascular Center), Yoshimitsu Fukushima(Saitama Children's Medical Center), Masahiro Inoue(Kyoto University), Masahiro Nakayama(Osaka International Cancer Institute), Hidefumi Tonoki(Sapporo University), Norio Niikawa(Nagasaki University), Yosuke Komoto(The University of Osaka), Hirofumi Ohashi(Saitama Children's Medical Center), Sachiko Ohishi(National Cerebral and Cardiovascular Center), Akira Okada(The University of Osaka), Elisabeth Steichen(Innsbruck Medical University)
Cited by 94
Related Papers
Kabuki make‐up (Niikawa‐Kuroki) syndrome: A study of 62 patients
|American Journal of Medical Genetics|1988|457
An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome
|Nature Genetics|1996|385
Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse
|Nature Genetics|1995|291
Analysis of germline CDKN1C (p57<sup>KIP2</sup>) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation
|Journal of Medical Genetics|1999|178
Common variants in CASP3 confer susceptibility to Kawasaki disease
|Human Molecular Genetics|2010|176